Jan. 25, 2021
1:30 p.m. CST
Femke H. Bouwman will outline and summarize 2020's most impactful findings in retinal biomarker development in AD. Jessica Alber will discuss up and coming developments for 2021, as well as the PIA5's goals to chart a path forward towards retinal biomarker validation in AD. Following these presentations, there will be a group discussion led by the PIA Executive Committee. Moderated by Victoria Pelak and Robert Rissman.
Femke H. Bouwman and Jessical Alber